‘Designer drugs’: update on the management of novel psychoactive material misuse while in the acute treatment placingThe public health risks linked with ?-PVP rely on numerous factors: frequency and means of administration, accessibility and drug properties, the assortment of data between consumers, and adverse wellbeing effects. There exists a